OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors
Maria Reinecke, P. Brear, Larsen Vornholz, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 5, pp. 577-585
Open Access | Times Cited: 36
Maria Reinecke, P. Brear, Larsen Vornholz, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 5, pp. 577-585
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
George S. Biggs, Emma E. Cawood, Aini Vuorinen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
George S. Biggs, Emma E. Cawood, Aini Vuorinen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
AI-driven multi-omics integration for multi-scale predictive modeling of genotype-environment-phenotype relationships
You Wu, Lei Xie
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 265-277
Open Access | Times Cited: 2
You Wu, Lei Xie
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 265-277
Open Access | Times Cited: 2
Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics
Stephan Eckert, Nicola Berner, Karl Kramer, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 11
Stephan Eckert, Nicola Berner, Karl Kramer, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 11
Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response
Stefanie Höfer, Larissa Frasch, Sarah Brajkovic, et al.
Molecular Systems Biology (2025)
Open Access | Times Cited: 1
Stefanie Höfer, Larissa Frasch, Sarah Brajkovic, et al.
Molecular Systems Biology (2025)
Open Access | Times Cited: 1
Exploring affinity chromatography in proteomics: A comprehensive review
Ivo Chamrád, Radim Simerský, René Lenobel, et al.
Analytica Chimica Acta (2024) Vol. 1306, pp. 342513-342513
Closed Access | Times Cited: 6
Ivo Chamrád, Radim Simerský, René Lenobel, et al.
Analytica Chimica Acta (2024) Vol. 1306, pp. 342513-342513
Closed Access | Times Cited: 6
Poly-pharmacology of existing drugs: How to crack the code?
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Comprehensive detection and characterization of human druggable pockets through novel binding site descriptors
Arnau Comajuncosa-Creus, Guillem Jorba, Xavier Barril, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Arnau Comajuncosa-Creus, Guillem Jorba, Xavier Barril, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
AI-empowered perturbation proteomics for complex biological systems
Liujia Qian, Rui Sun, Ruedi Aebersold, et al.
Cell Genomics (2024) Vol. 4, Iss. 11, pp. 100691-100691
Open Access | Times Cited: 4
Liujia Qian, Rui Sun, Ruedi Aebersold, et al.
Cell Genomics (2024) Vol. 4, Iss. 11, pp. 100691-100691
Open Access | Times Cited: 4
Chemoproteomic Profiling of C. albicans for Characterization of Anti-fungal Kinase Inhibitors
David J. Shirley, Meganathan Nandakumar, Aurora Cabrera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
David J. Shirley, Meganathan Nandakumar, Aurora Cabrera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Automated High-Throughput Affinity Capture-Mass Spectrometry Platform with Data-Independent Acquisition
Hui Jing, Paul L. Richardson, Gregory K. Potts, et al.
Journal of Proteome Research (2025)
Closed Access
Hui Jing, Paul L. Richardson, Gregory K. Potts, et al.
Journal of Proteome Research (2025)
Closed Access
Resistance to Allosteric Inhibitors
Ian R. Outhwaite, Isabelle Kwan, Neil P. Shah, et al.
(2025)
Closed Access
Ian R. Outhwaite, Isabelle Kwan, Neil P. Shah, et al.
(2025)
Closed Access
Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets
Isabelle Rose Leo, Elena Kunold, Anastasia Audrey, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Isabelle Rose Leo, Elena Kunold, Anastasia Audrey, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Insights into the cellular function and mechanism of action of quinone reductase 2 (NQO2)
Faiza Islam, Brian H. Shilton
Biochemical Journal (2025) Vol. 482, Iss. 06, pp. 309-324
Open Access
Faiza Islam, Brian H. Shilton
Biochemical Journal (2025) Vol. 482, Iss. 06, pp. 309-324
Open Access
Chemoproteomic Profiling of C. albicans for Characterization of Antifungal Kinase Inhibitors
David J. Shirley, Meganathan Nandakumar, Aurora Cabrera, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
David J. Shirley, Meganathan Nandakumar, Aurora Cabrera, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Data-oriented protein kinase drug discovery
Elena Xerxa, Jürgen Bajorath
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116413-116413
Open Access | Times Cited: 3
Elena Xerxa, Jürgen Bajorath
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116413-116413
Open Access | Times Cited: 3
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily
Daniela Digles, Álvaro Inglés‐Prieto, Vojtech Dvorak, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Daniela Digles, Álvaro Inglés‐Prieto, Vojtech Dvorak, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Inhibitor-induced supercharging of kinase turnover via endogenous proteolytic circuits
Natalie S. Scholes, Martino Bertoni, Arnau Comajuncosa-Creus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Natalie S. Scholes, Martino Bertoni, Arnau Comajuncosa-Creus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018-present)
Shirong Bian, Ru Zhang, Jianyu Nie, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 789-806
Closed Access | Times Cited: 2
Shirong Bian, Ru Zhang, Jianyu Nie, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 789-806
Closed Access | Times Cited: 2
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa, Albert A. Antolín
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1043-1069
Closed Access | Times Cited: 2
Leticia Manen-Freixa, Albert A. Antolín
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1043-1069
Closed Access | Times Cited: 2
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
George S. Biggs, Emma E. Cawood, Aini Vuorinen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
George S. Biggs, Emma E. Cawood, Aini Vuorinen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
Filip Miljković, Jürgen Bajorath
Molecular Pharmaceutics (2024) Vol. 21, Iss. 10, pp. 4849-4859
Closed Access | Times Cited: 2
Filip Miljković, Jürgen Bajorath
Molecular Pharmaceutics (2024) Vol. 21, Iss. 10, pp. 4849-4859
Closed Access | Times Cited: 2
The 2024 Report on the Human Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Sandra Orchard, Lydie Lane, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 12, pp. 5296-5311
Closed Access | Times Cited: 2
Gilbert S. Omenn, Sandra Orchard, Lydie Lane, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 12, pp. 5296-5311
Closed Access | Times Cited: 2
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships
Christopher R. M. Asquith, Michael P. East, Tuomo Laitinen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116357-116357
Open Access | Times Cited: 1
Christopher R. M. Asquith, Michael P. East, Tuomo Laitinen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116357-116357
Open Access | Times Cited: 1
Microplate-Based Enzymatic Activity Assay Protocol Powered by Activity-Based Probes
Exequiel O. J. Porta, Karunakaran Kalesh, Jaime A. Isern, et al.
(2024)
Open Access | Times Cited: 1
Exequiel O. J. Porta, Karunakaran Kalesh, Jaime A. Isern, et al.
(2024)
Open Access | Times Cited: 1
Microplate-Based Enzymatic Activity Assay Protocol Powered by Activity-Based Probes
Exequiel O. J. Porta, Karunakaran Kalesh, Jaime A. Isern, et al.
(2024)
Open Access | Times Cited: 1
Exequiel O. J. Porta, Karunakaran Kalesh, Jaime A. Isern, et al.
(2024)
Open Access | Times Cited: 1
